PathAI, a company that provides AI-powered technology for advancing pathology research, announced on Tuesday that it has named Pathologist and executive leader Eric Walk, MD, FCAP, as its new chief medical officer.
In the new role, Dr Walk is to manage Clinical, Regulatory, Medical Affairs and Pathology teams.
Dr Walk has held the position of chief medical & scientific officer and SVP of Medical and Scientific Affairs at Roche Tissue Diagnostics (Ventana Medical Systems). He was a member of the Roche Medical Leadership Team establishing the global medical strategy for the Diagnostics division. He has worked at Novartis Oncology in Translational Medicine and Early Clinical Development.
Teva's Prolia biosimilar candidate accepted for review by FDA and EMA
Boehringer receives Breakthrough Therapy designation for survodutide
IRLAB Therapeutics reports start of Phase I study for IRL757
GBI Biomanufacturing agrees manufacturing collaboration with Allterum Therapeutics
MediLink enters clinical trial collaboration and supply agreement with Amgen
Innovent Biologics partners with Jiangsu Aosaikang Pharmaceutical for lung cancer treatment
Selonterra receives second grant from Michael J Fox Foundation for Parkinson's Research
Genprex research collaborators to present positive data on Reqorsa Gene Therapy at SITC 2024
Thermo Fisher Scientific announces expanded biopharma services
GE HealthCare reports promising Phase I results for innovative manganese-based MRI contrast agent
hVIVO reports positive results from RSV antiviral human challenge trial
TiumBio doses first patient in phase two TU2218 clinical trial
BerGenBio reveals preliminary safety data from Phase 1b BGBC016 study in first-line NSCLC patients
ABL Bio signs clinical trial collaboration and supply agreement with MSD